This MS treatment causes frequent skin issues Published: 28 July 2021 Skin reactions are common in people with multiple sclerosis (MS) who are being treated with oral Mavenclad (cladribine) a new real-world study from Germany has found.  Almost a third (32%) of people studied developed some form of skin reaction